MannKind Corporation

The current price of MNKD is $3.93 — it has increased by 5.36% since the previous close. Data as of Nov 4, 2026.

MNKD is up 12.29% over the past week, up 3.42% over the past month and down 28.28% over the past year. The price is above its 200-day moving average of $3.71.

Analysts' average 12-month price target for MNKD is $10.00, which implies 154.45% upside from the current price. Individual estimates range from $7.00 to $13.00.

Of the 9 analysts covering MannKind Corporation, 8 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

MannKind Corporation has a market capitalization of $1.26B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, MannKind Corporation posted a loss of $0.06 per share against an estimate of -$0.0075, missing expectations by 700.00%. Upcoming reports are listed in the earnings calendar.

MannKind Corporation reported revenue of $109.37M in its most recent quarter, which has increased by 42.92% compared with the same quarter a year earlier. Analysts had expected $108.08M.

MannKind Corporation has not paid any dividends over the past year.

Companies most comparable to MannKind Corporation include Xeris Biopharma Holdings, Inc., Avalyn Pharma Inc. Common Stock, Theravance Biopharma Inc, ARS Pharmaceuticals, Inc. and Oramed Pharmaceuticals Inc.

In the latest trading session MNKD moved between $3.80 and $4.05, a range of 6.23% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of MannKind Corporation shows a strong buy rating today. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for MannKind Corporation is sell. Technical ratings are indicators, not investment advice.

Over the past 52 weeks MNKD has traded between $2.23 and $6.51. The current price is 39.63% below its 52-week high.